A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
Knoop
M
M
Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California.
Cramer
D V
DV
Chapman
F C
FC
Makowka
L
L
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D051381:Rats; D011912:Rats, Inbred ACI; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013997:Time Factors; D014184:Transplantation, Homologous; D011798:Quinaldines
D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; C046943:brequinar; D011798:Quinaldines